Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5341 to 5355 of 7685 results

  1. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and calcium channel blockers, including compared with placebo, for adults with aortic regurgitation?

    Recommendation ID NG208/15 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  2. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with primary severe mitral regurgitation?

    Recommendation ID NG208/16 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  3. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with severe aortic stenosis?

    Recommendation ID NG208/14 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  4. Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture (including electroacupuncture) as an adjunct to aid withdrawal from opioids?

    Recommendation ID NG215/09 Question Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture

    Research recommendation
    Published
    11 May 2022

  5. Intensive rehabilitation therapies after hip fracture: What is the clinical and cost effectiveness of additional intensive physiotherapy and/or occupational therapy (for example, progressive resistance training) after hip fracture?

    Recommendation ID CG124/04 Question Intensive rehabilitation therapies after hip fracture: What is the clinical and cost effectiveness

    Research recommendation
    Published
    3 February 2023

  6. What is the clinical and cost effectiveness of a double application of antiseptic to the skin at the surgical site compared with a single application?

    Recommendation ID NG125/8 Question What is the clinical and cost effectiveness of a double application of antiseptic to the skin at the

    Research recommendation
    Published
    26 October 2020

  7. Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of beta‑blockers for adults over 75 years with non‑rheumatic/calcific mitral stenosis, in both sinus rhythm and atrial fibrillation?

    Recommendation ID NG208/17 Question Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness

    Research recommendation
    Published
    16 December 2021

  8. Blood pressure targets: What is the clinical and cost effectiveness of a lower blood pressure treatment target relative to the standard blood pressure treatment target for people with aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/12 Question Blood pressure targets: What is the clinical and cost effectiveness of a lower blood pressure treatment

    Research recommendation
    Published
    12 December 2022

  9. What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in adults, young people and children?

    Recommendation ID NG191/9 Question What is the clinical and cost effectiveness of budesonide for treating COVID-19 in the community in

    Research recommendation
    Published
    12 November 2021

  10. What is the clinical and cost effectiveness of alternative treatments as firstline treatment for trigeminal neuralgia compared with other better-tolerated pharmacological treatments?

    Recommendation ID CG173/10 Question What is the clinical and cost effectiveness of alternative treatments as firstline treatment for trigeminal

    Research recommendation
    Published
    26 October 2020

  11. Pulmonary hypertension:- What are the most clinical and cost-effective treatments for pulmonary hypertension in people with COPD?

    Recommendation ID NG115/10 Question Pulmonary hypertension:- What are the most clinical and cost-effective treatments for pulmonary hypertension

    Research recommendation
    Published
    13 February 2019

  12. Managing delirium superimposed on dementia:- What are the most clinically and cost-effective non-pharmacological interventions for helping the long-term recovery of people with delirium superimposed on dementia?

    Recommendation ID NG97/4 Question Managing delirium superimposed on dementia:- What are the most clinically and cost-effective non-pharmacological

    Research recommendation
    Published
    10 December 2018

  13. Withdrawal interventions for gabapentinoids: What are the most clinically and cost-effective strategies or interventions to aid withdrawal of gabapentinoids?

    Recommendation ID NG215/10 Question Withdrawal interventions for gabapentinoids: What are the most clinically and cost-effective strategies

    Research recommendation
    Published
    11 May 2022

  14. Antimicrobial management of Lyme disease:- What are the most clinically and cost-effective treatment options for different clinical presentations of Lyme disease in the UK?

    Recommendation ID NG95/4 Question Antimicrobial management of Lyme disease:- What are the most clinically and cost-effective treatment

    Research recommendation
    Published
    27 November 2018

  15. Increasing pertussis vaccination uptake by pregnant women: What are the most effective and acceptable interventions to increase pertussis vaccine uptake in pregnant women in the UK?

    Recommendation ID NG218/08 Question Increasing pertussis vaccination uptake by pregnant women: What are the most effective and acceptable

    Research recommendation
    Published
    31 May 2022